The Inflammatory Pain Treatment Market was valued at USD 12.5 billion in 2024 and is projected to reach USD 25.0 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by a confluence of factors including the rising prevalence of chronic inflammatory diseases, increasing healthcare expenditure, and advancements in pain management therapies. The demand for effective...